发明公开
- 专利标题： GLYCINE TRANSPORTER INHIBITOR
- 专利标题（中）： 甘氨酸转运蛋白抑制剂
-
申请号： EP10753606.2申请日： 2010-03-19
-
公开(公告)号： EP2409976A1公开(公告)日： 2012-01-25
- 发明人: YASUHARA, Akito , YAMAMOTO, Shuji , OHTA, Hiroshi , SHIRASAKI, Yoshihisa , SAKAGAMI, Kazunari , HAYASHI, Masato , SHIBATA, Tsuyoshi , SHIMAZAKI, Youichi , ARAKI, Yuko , ABE, Kumi , SUN, Xiang-Min
- 申请人： Taisho Pharmaceutical Co., Ltd.
- 申请人地址： 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633 JP
- 专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人： Taisho Pharmaceutical Co., Ltd.
- 当前专利权人地址： 24-1, Takada 3-chome Toshima-ku Tokyo 170-8633 JP
- 代理机构： HOFFMANN EITLE
- 优先权： JP2009067945 20090319
- 国际公布： WO2010107115 20100923
- 主分类号： C07D405/12
- IPC分类号： C07D405/12 ; A61K31/4178 ; A61K31/4196 ; A61K31/437 ; A61K31/4439 ; A61P25/08 ; A61P25/14 ; A61P25/18 ; A61P25/20 ; A61P25/22 ; A61P25/24 ; A61P25/28 ; A61P25/30 ; A61P43/00 ; C07D405/14 ; C07D409/12 ; C07D471/04
摘要：
The present invention aims to provide novel compounds of formula [I] or pharmaceutically acceptable salts thereof that are based on a glycine uptake inhibiting action and which are useful in the prevention or treatment of such diseases as schizophrenia, Alzheimer's disease, cognitive dysfunction, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsory disorder, social anxiety disorder, posttraumatic stress disorder, specific phobia, acute stress disorder, etc.), depression, drug addiction, spasm, tremor, and sleep disorder:
信息查询
